Levofloxacin

Product NDC
21695-027
11-digit product format
216950027
Labeler code
21695
Product ID
21695-027_f82ee9e3-5119-4be0-883c-5831386baef6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Levofloxacin
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Rebel Distributors Corp
Application
ANDA076361
Marketing category
ANDA
Marketing start
2011-06-20
Marketing end
0000-00-00
Substance
LEVOFLOXACIN
Active strength
500 mg/1
Pharmacologic classes
Quinolone Antimicrobial [EPC],Quinolones [CS]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
addb5519-f7ae-4d4e-b9ca-f782a1597fd3Product name220210610
fb758c6a-fdee-40a8-99c2-46f79c3ff90cProduct name420200807
1a81e9a9-11c3-4fcf-b5dd-f6798fef8e6dProduct name120190618
aea4a616-4dfe-45f6-94bb-8b9063056cebProduct name620190611
2246ce8e-a477-4dc3-b6d6-fe9973c18ed1Product name120180821
5a6c788d-375b-4565-a8ae-67c179a30c93Product name120180212

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
21695-027-032019-09-24C16284748780-1934fe258-4809-48b1-e053-8cdaa90a720aThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets for oral use Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs, levofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
21695-027-072019-09-24C16284748780-1934fe258-4809-48b1-e053-8cdaa90a720aThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets for oral use Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs, levofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
21695-027-102019-09-24C16284748780-1934fe258-4809-48b1-e053-8cdaa90a720aThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets for oral use Initial U.S. Approval: 1996 To reduce the development of drug-resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs, levofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
21695-027-03Levofloxacin3 in 1 BOTTLETABLET, FILM COATED33
21695-027-07Levofloxacin7 in 1 BOTTLETABLET, FILM COATED73
21695-027-10Levofloxacin10 in 1 BOTTLETABLET, FILM COATED103

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
21695-027-03EA - Each21695-0270cf9a395-3282-4d06-843d-746eff1930d012013-02-13
21695-027-07EA - Each21695-027f7b4adbb-fcf5-4ca2-9471-35132242e79412012-07-24
21695-027-10EA - Each21695-027687a61c8-6328-4520-8d9a-ad78e634467d12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LEVOFLOXACINACTIVE INGREDIENT6GNT3Y5LMFLEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
LEVOFLOXACINACTIVE MOIETY6GNT3Y5LMFLEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTLEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
HYDROXYPROPYL CELLULOSEINACTIVE INGREDIENTRFW2ET671PLEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
HYPROMELLOSE 2910 (3 MPA.S)INACTIVE INGREDIENT0VUT3PMY82LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
HYPROMELLOSE 2910 (6 MPA.S)INACTIVE INGREDIENT0WZ8WG20P6LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQLEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HLEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
TALCINACTIVE INGREDIENT7SEV7J4R1ULEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPLEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
21695-027LEVOFLOXACIN TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]3Legacy NDC, 3 package rows20120511_312e65cb-897f-4c24-b17b-be7e8ce469bb.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
199884levoFLOXacin 250 MG Oral TabletPSN312e65cb-897f-4c24-b17b-be7e8ce469bb3
199885levoFLOXacin 500 MG Oral TabletPSN312e65cb-897f-4c24-b17b-be7e8ce469bb3
311296levoFLOXacin 750 MG Oral TabletPSN312e65cb-897f-4c24-b17b-be7e8ce469bb3
199884levofloxacin 250 MG Oral TabletSCD312e65cb-897f-4c24-b17b-be7e8ce469bb3
199885levofloxacin 500 MG Oral TabletSCD312e65cb-897f-4c24-b17b-be7e8ce469bb3
311296levofloxacin 750 MG Oral TabletSCD312e65cb-897f-4c24-b17b-be7e8ce469bb3
199884levofloxacin (as levofloxacin hemihydrate) 250 MG Oral TabletSY312e65cb-897f-4c24-b17b-be7e8ce469bb3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
21695-027-03216950027033 in 1 BOTTLEHistorical
21695-027-07216950027077 in 1 BOTTLEHistorical
21695-027-102169500271010 in 1 BOTTLEHistorical